Drug interactions
Brentuximab + Efgartigimod alfa
Severity: Moderate
Brentuximab and Efgartigimod alfa: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Brentuximab vedotin is an IgG1 antibody-drug conjugate, so its clearance could increase and exposure fall. The clinical significance is uncertain.
What this interaction means in plain words
Brentuximab and Efgartigimod alfa can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Brentuximab belongs to Oncology; Efgartigimod alfa belongs to Miscellaneous.
Why it happens
Efgartigimod blocks FcRn-mediated IgG recycling, which may accelerate catabolism of the antibody component of brentuximab vedotin.
What to do
Monitor lymphoma response closely if both are required. Involve oncology and neurology specialists in weighing alternatives.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab and Efgartigimod alfa, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Brentuximab
- Bleomycin + Brentuximab Contraindicated
- Brentuximab + Dengue vaccine Major
- Brentuximab + Etrasimod Major
- Brentuximab + Idelalisib Major
- Brentuximab + Levoketoconazole Major
- Brentuximab + Nefazodone Major
Other interactions of Efgartigimod alfa
- Adalimumab + Efgartigimod alfa Moderate
- Ado-trastuzumab + Efgartigimod alfa Moderate
- Basiliximab + Efgartigimod alfa Moderate
- Bevacizumab + Efgartigimod alfa Moderate
- Denosumab + Efgartigimod alfa Moderate
- Efgartigimod alfa + Galcanezumab Moderate
Frequently asked questions
Can I take Brentuximab with Efgartigimod alfa?
MediHelp rates the interaction as moderate. Brentuximab and Efgartigimod alfa can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Brentuximab vedotin is an IgG1 antibody-drug conjugate, so its clearance could increase and exposure fall. The clinical significance is uncertain.
How serious is the interaction between Brentuximab and Efgartigimod alfa?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor lymphoma response closely if both are required. Involve oncology and neurology specialists in weighing alternatives.
What other medicines interact with Brentuximab?
MediHelp also lists interactions of Brentuximab with, for example, Bleomycin, Dengue vaccine, Etrasimod. The full list is on the Brentuximab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
